Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 1:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Traumatic Brain Injury
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois • Houston, Texas

Conditions: Cardio Vascular Disease, Cerebro Vascular Disease, Mental Health, Chronic Disease (Physical)
Interventions: Qungasvik-Healthy Hearts; Behavioral
Lead sponsor: University of Alaska Fairbanks; Other
Eligibility: 12 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Fairbanks, Alaska

Conditions: Pulmonary Arterial Hypertension
Interventions: Not listed
Lead sponsor: Actelion; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 84
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 65 more

Conditions: Pulmonary Hypertension
Interventions: Magnetic resonance Imaging; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Ocular Hypertension
Interventions: Scleral Lens, No lens; Device · Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hypertension Disorders in Pregnancy, Blood Pressure Measurement in Pregnancy, Inspiratory Strength Training (IST), Pregnancy
Interventions: Exercise at 15% PI max, Exercise at 50% PI max; Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Eclampsia
Interventions: Dexamethasone; Drug
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: White Coat Hypertension, Hypertension, Blood Pressure, Anxiety, Virtual Reality Exposure Therapy, Ambulatory Blood Pressure Monitoring, Blood Pressure Disorders
Interventions: Virtual Reality Exposure; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Atherosclerosis, Heart Failure, Congestive, Hypertension, Myocardial Infarction
Interventions: Angiotensin II type 1 receptor antagonists; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hypertension, COVID
Interventions: ACEI/ARB, Non-ACEI/ARB, ACEI, ARB; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 22,213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Primary Open-angle Glaucoma
Interventions: iStent; Device
Lead sponsor: Glaukos Corporation; Industry
Eligibility: Not listed
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 18
States / cities: Chico, California • Huntington Beach, California • Napa, California + 15 more

Conditions: Pulmonary Arterial Hypertension, Renal Dysfunction
Interventions: UT-15C SR (treprostinil diethanolamine); Drug
Lead sponsor: United Therapeutics; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Gastrointestinal Cancers, Prostate Cancer, Hypertension
Interventions: Vitamin D, Placebo; Drug · Dietary Supplement
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 30 Years to 80 Years
Enrollment: 328 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension
Interventions: Lifelight, Manual sphygmomanometer; Device
Lead sponsor: Xim Limited; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Hypertension
Interventions: Azilsartan Medoxomil, Valsartan; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 984 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 77
States / cities: Huntsville, Alabama • Glendale, Arizona • Phoenix, Arizona + 74 more

Conditions: Glaucoma, Open Angle or Ocular Hypertension
Interventions: brinzolamide 1% ophthalmic suspension, Azopt 1%; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Hypertension, Hypercholesterolemia, Dementia Risk Factors
Interventions: Angiotensin Receptor Blockers (ARBs), Hydrophilic Statins or Non-Statin Alternative; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 50 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension
Interventions: telmisartan 80 mg/hydrochlorothiazide 25 mg, valsartan 160 mg/hydrochlorothiazide 25 mg, placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 1,109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 100
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 90 more

Conditions: Chronic Kidney Diseases, Cardiovascular Diseases, Hypertension
Interventions: Fruits and Vegetables; Other
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertension
Interventions: Low sodium diet, high sodium diet; Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 30 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2030
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Hypertension
Interventions: Aliskiren, Hydrochlorothiazide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 532 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Diabetes Mellitus Self Management Education, Hypertension Self-management, Self Management
Interventions: Remote patient monitoring, Telephone; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Ocular Hypertension, Glaucoma
Interventions: Massage, Experimental insert, Sham insert; Device · Procedure
Lead sponsor: Temple University; Other
Eligibility: 30 Years to 90 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: Computerized reminders about treatment guidelines to providers who care for hypertensive patients; Behavioral
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 20 Years and older
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Predict Severe Traumatic Brain Injury

Qungasvik (Toolbox)-Healthy Hearts: A Cultural Approach to Reducing Chronic Disease Risk

A Registry for Patients Taking Uptravi

Cardiac MRI in Pulmonary Hypertension

The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width

Breathing for Two: Inspiratory Muscle Strength Training for Supporting Healthy Blood Pressure in Pregnancy

Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES):

Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry

The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil

Vitamin D for Chemoprevention

Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Vascular Intervention Strategies Trial for Alzheimer's

A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

Cardiorenal Protective Diet

Renal Metabolism in Salt-sensitive Human Blood Pressure

Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension

The Mobile Health and Wellness Program Remote Health Study

Foot Reflexology in Ocular Hypertensive and Glaucoma Patients

Impact of Computerized Reminders on Blood Pressure Documentation and Control